Cas:856563-08-1 (R)-3-(1-aminoethyl)phenol hydrochloride manufacturer & supplier

We serve Chemical Name:(R)-3-(1-aminoethyl)phenol hydrochloride CAS:856563-08-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(R)-3-(1-aminoethyl)phenol hydrochloride

Chemical Name:(R)-3-(1-aminoethyl)phenol hydrochloride
CAS.NO:856563-08-1
Synonyms:3-(aminoethyl)phenol,chloride;R-3-Hydroxy-Alpha-methylbenzylamine hydrochloride
Molecular Formula:C8H12ClNO
Molecular Weight:173.64000
HS Code:2922299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:46.25000
Exact Mass:173.06100
LogP:2.91420

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-(aminoethyl)phenol,chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,R-3-Hydroxy-Alpha-methylbenzylamine hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,R-3-Hydroxy-Alpha-methylbenzylamine hydrochloride Use and application,R-3-Hydroxy-Alpha-methylbenzylamine hydrochloride technical grade,usp/ep/jp grade.


Related News: As the Covid-19 pandemic continues to challenge the global drug supply chain, nations are looking for new ways to enable native producers to continue scaling up. Now, an Israeli API maker is dropping a down payment into an Indian intermediates company to ramp up its own manufacturing base. 1,1-diethyl-2-propan-2-ylhydrazine manufacturers About eight months after originally teaming up on neuromuscular diseases, Takeda and PeptiDream have expanded the pact to include several central nervous system targets, while revealing the tie-up could be worth more than $3.5 billion. 1-(2,4-dichlorophenyl)-3-(2,4-dimethylphenyl)propan-1-one suppliers Over the duration of this study, investigators observed a 4.2% reduction in annualised absolute risk of cardiovascular death or heart failure hospitalisations compared to placebo. (S)-(-)-allyl sec-butyl sulfone vendor & factory.